免疫檢測市場規模、佔有率和成長分析（按產品、技術、檢體、應用、最終用戶和地區分類）—產業預測（2026-2033 年）

預計到 2024 年，全球免疫檢測市場規模將達到 351.2 億美元，到 2025 年將達到 370.8 億美元，到 2033 年將達到 573 億美元，預測期（2026-2033 年）的複合年成長率為 5.59%。

全球免疫檢測市場正經歷顯著成長，這主要得益於技術進步、診斷測試需求的成長以及在環境檢測和臨床診斷生物製藥領域應用範圍的擴大。然而，檢測法的變異性以及開發複雜免疫檢測的高成本等挑戰可能會阻礙市場成長。創新免疫檢測的開發需要大量投資，這對該領域的許多公司構成了障礙。儘管存在這些挑戰，人們對個人化醫療日益成長的興趣，以及來自公共和公共部門不斷增加的研究經費，可能會加速免疫檢測的應用，從而創造新的機會。

推動全球免疫檢測市場發展的因素

由於旨在促進醫療發展和研究的組織和政府機構不斷增加財政支持，全球免疫檢測市場正經歷顯著成長。資金的激增推動了創新免疫檢測解決方案的研發和改進。此外，私營部門對治療和診斷研究的持續投入也進一步刺激了對這些先進解決方案的需求。私人投資與政府支持的相互作用，成為推動免疫檢測市場發展和演進的強大催化劑，促進了更有效的醫療技術和調查方法的發展。

全球免疫檢測市場面臨的限制因素

由於醫療基礎設施匱乏和對免疫檢測技術認知度低，全球免疫檢測市場在某些發展中地區面臨嚴峻挑戰。這種認知不足會阻礙市場成長，因為潛在使用者無法充分了解這些技術的優勢。此外，該領域對教育和培訓的需求也構成了經濟和後勤方面的障礙，進一步加劇了這一局面。缺乏能夠解讀結果並有效操作免疫檢測的專業人員也限制了市場滲透率，抑制了整體需求，最終影響了該細分市場的成長潛力。

全球免疫檢測市場趨勢

全球免疫檢測市場正經歷顯著成長，這主要得益於感染疾病和慢性病的日益增多，這些疾病需要有效的疾病監測和檢測解決方案。免疫檢測正成為生物製藥領域的重要工具，有助於治療監測和新藥研發。此外，免疫分析在環境監測領域的應用範圍不斷擴大，尤其是在污染物和有害物質的識別方面，也提升了該市場的重要性。這些多元化的需求推動了市場的動態發展，凸顯了免疫檢測在醫療保健和環境領域的多功能性和重要性，並使其成為診斷和監測解決方案領域的主要發展趨勢。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 一手和二手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析
• 技術分析
• 專利分析

全球免疫檢測市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 試劑和試劑盒
  • ELISA試劑和試劑盒
  • CLIA試劑和試劑盒
  • IFA試劑和試劑盒
  • 快速檢測試劑和試劑盒
  • ELISpot試劑和試劑盒
  • 西方墨點法試劑與試劑盒
  • 其他試劑和試劑盒
• 分析器
  • 按類型
  • 開放式系統
  • 封閉式系統
  • 透過購買方式
  • 租賃購買
  • 大量購買

全球免疫檢測市場規模（依技術及複合年成長率分類）（2026-2033 年）

• ELISA
• 化學冷光免疫檢測（CLIA）
• 螢光（IFA）
• 快速檢測
• ELISpot
• 蛋白質印跡法
• 其他

全球免疫檢測市場規模（按檢體和複合年成長率分類）（2026-2033 年）

• 血
• 唾液
• 尿
• 其他

全球免疫檢測市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 感染疾病
• 內分泌學
• 腫瘤學
• 骨骼和礦物質代謝紊亂
• 心臟病學
• 血液篩檢
• 自體免疫疾病
• 過敏診斷
• 毒理學
• 新生兒篩檢
• 其他

全球免疫檢測市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院診所
• 臨床檢查室
• 製藥生物技術公司和合約研究組織
• 血庫
• 研究與學術實驗室
• 居家醫療

全球免疫檢測市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • GCC
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

  主要企業簡介

  • 雅培實驗室（美國）
  • F. Hoffmann-La Roche AG（瑞士）
  • 賽默飛世爾科技公司（美國）
  • 西門子醫療股份公司（德國）
  • 丹納赫公司（美國）
  • 貝克頓·迪金森公司（BD）（美國）
  • Bio-Rad Laboratories, Inc.（美國）
  • 凱傑公司（德國/荷蘭）
  • Sysmex公司（日本）
  • 默克集團（德國）
  • 迪亞索林公司（義大利）
  • 生物梅里埃公司（法國）
  • QuidelOrtho 公司（美國）
  • 安捷倫科技公司（美國）
  • Hologic公司（美國）
  • 珀金埃爾默公司（美國）
  • Luminex公司（美國）
  • 奧特博診斷有限公司（中國）
  • 貝克曼庫爾特公司（美國）
  • 蘭道克斯實驗室（英國）

結論與建議

Global Immunoassay Market size was valued at USD 35.12 Billion in 2024 and is poised to grow from USD 37.08 Billion in 2025 to USD 57.3 Billion by 2033, growing at a CAGR of 5.59% during the forecast period (2026-2033).

The global immunoassay market is experiencing noteworthy expansion, driven by advancements in technology, increasing demand for diagnostic testing, and a broadening of applications across environmental testing, clinical diagnostics, and biopharmaceuticals. However, challenges such as assay variability and the high costs associated with the development of complex immunoassays can hinder market growth. The development of innovative immunoassays requires substantial investment, presenting a barrier for many players in the field. Despite these challenges, opportunities are emerging, particularly with the rising interest in personalized medicine, which is likely to boost the utilization of immunoassays, alongside increased funding for research initiatives from both private and public sectors.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Immunoassay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Immunoassay Market Segments Analysis

Global Immunoassay Market is segmented by Product, Technology, Specimen, Application, End User and region. Based on Product, the market is segmented into Reagents & Kits and Analyzers. Based on Technology, the market is segmented into ELISA, Chemiluminescence Immunoassay (CLIA), Immunofluorescence assay (IFA), Rapid Tests, ELISpot, Western Blotting and Other Technologies. Based on Specimen, the market is segmented into Blood, Saliva, Urine and Other Specimens. Based on Application, the market is segmented into Infectious Diseases, Endocrinology,Oncology, Bone & Mineral Disorders, Cardiology, Blood Screening, Autoimmune Disorders, Allergy Diagnostics, Toxicology, Newborn Screening and Other Applications. Based on End User, the market is segmented into Hospitals & Clinics, Clinical Laboratories, Pharmaceutical & Biotechnology Companies and CROs, Blood Banks, Research & Academic Laboratories and Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Immunoassay Market

The Global Immunoassay market is experiencing significant growth due to increased financial support from both organizations and government entities aimed at advancing healthcare development and research. This surge in funding fosters the creation and enhancement of innovative immunoassay solutions. Additionally, heightened investments from the private sector in both therapeutic and diagnostic research are further propelling the demand for these advanced solutions. The interplay of private investments and supportive government initiatives is thus acting as a powerful catalyst for the expansion and evolution of the immunoassay market, facilitating the development of more effective healthcare technologies and methodologies.

Restraints in the Global Immunoassay Market

The global immunoassay market faces significant challenges in certain developing regions due to inadequate healthcare infrastructure and a general lack of awareness regarding immunoassay techniques. This limited understanding can hinder market growth, as potential users may not fully appreciate the benefits of these technologies. Additionally, the need for education and training in this area can present financial and logistical obstacles, further complicating the situation. The scarcity of skilled professionals capable of interpreting results and effectively operating immunoassays also restricts market adoption and diminishes overall demand, ultimately impacting the growth potential of this market segment.

Market Trends of the Global Immunoassay Market

The Global Immunoassay market is witnessing significant growth driven by the increasing prevalence of infections and chronic diseases necessitating effective disease monitoring and detection solutions. Immunoassays are becoming essential tools for the biopharmaceutical sector, facilitating therapeutic monitoring and the development of novel drugs. Additionally, their expanding applications in environmental monitoring-particularly for identifying pollutants and contaminants-are enhancing their market relevance. This multi-faceted demand is contributing to the market's dynamic evolution, highlighting the versatility and critical importance of immunoassays across healthcare and environmental sectors, thus establishing it as a key trend in the landscape of diagnostics and monitoring solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Patent Analysis

Global Immunoassay Market Size by Product & CAGR (2026-2033)

• Market Overview
• Reagents & Kits
  • ELISA Reagents & Kits
  • CLIA Reagents & Kits
  • IFA Reagents & Kits
  • Rapid Test Reagent & Kits
  • ELISpot Reagent & Kits
  • Western Blot Reagent & Kits
  • Other Reagents & Kits
• Analyzers
  • By Type
  • Open-ended Systems
  • Closed-ended Systems
  • By Purchase Mode
  • Rental Purchase
  • Outright Purchase

Global Immunoassay Market Size by Technology & CAGR (2026-2033)

• Market Overview
• ELISA
• Chemiluminescence Immunoassay (CLIA)
• Immunofluorescence assay (IFA)
• Rapid Tests
• ELISpot
• Western Blotting
• Other Technologies

Global Immunoassay Market Size by Specimen & CAGR (2026-2033)

• Market Overview
• Blood
• Saliva
• Urine
• Other Specimens

Global Immunoassay Market Size by Application & CAGR (2026-2033)

• Market Overview
• Infectious Diseases
• Endocrinology
• Oncology
• Bone & Mineral Disorders
• Cardiology
• Blood Screening
• Autoimmune Disorders
• Allergy Diagnostics
• Toxicology
• Newborn Screening
• Other Applications

Global Immunoassay Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Clinical Laboratories
• Pharmaceutical & Biotechnology Companies and CROs
• Blood Banks
• Research & Academic Laboratories
• Home Care Settings

Global Immunoassay Market Size & CAGR (2026-2033)

• North America (Product, Technology, Specimen, Application, End User)
  • US
  • Canada
• Europe (Product, Technology, Specimen, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Specimen, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Specimen, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Specimen, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Germany/Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Autobio Diagnostics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations